title: The effects of UK-79,300, an orally-absorbed atriopeptidase inhibitor, in a conscious dog model of cardiac insufficiency.
authors.affiliation: Discovery Biology, Pfizer Central Research, Sandwich, Kent.
authors.forename: C T
authors.initials: CT
authors.lastname: Alabaster
authors.forename: I
authors.initials: I
authors.lastname: Machin
authors.forename: G M
authors.initials: GM
authors.lastname: Samuels
authors.forename: M R
authors.initials: MR
authors.lastname: Sutton
mesh_terms: D000818:Animals; D003509:Cyclohexanecarboxylic Acids; D004231:Diuresis / Q000187:drug effects*; D004285:Dogs; D006327:Heart Block / Q000188:drug therapy* / Q000503:physiopathology; D007189:Indans / Q000494:pharmacology*; D007192:Indenes / Q000494:pharmacology*; D009318:Natriuresis / Q000187:drug effects*; D015260:Neprilysin / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology*; D013237:Stereoisomerism
chemical_list: D003509:Cyclohexanecarboxylic Acids; D007189:Indans; D007192:Indenes; D011422:Propionates; C060942:candoxatrilat; C062766:candoxatril; D015260:Neprilysin